Kate Therapeutics

Developer of AAV-based gene therapies to treat genetically defined muscle disease

placeSan Diego, California, United States calendar_todayFounded 2020 groups46 employees language katetherapeutics.com

Registered entities

Innovation

15 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 947 times.

YearFilings
20232
20243
202510
202610

Investor mix

4 investors on record; lead investors include Westlake Village Biopartners, Versant Ventures; 1 has since exited.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon